Day: November 30, 2023

Figure 1: JR Zone Long SectionFigure 1: JR Zone Long SectionFigure 2: Jogran Porphyry: Cross-Sections Showing Drillhole LocationsFigure 2: Jogran Porphyry: Cross-Sections Showing Drillhole LocationsFigure 3: Richards Breccia Drillhole Location Map Showing Gradient IP AnomalyFigure 3: Richards Breccia Drillhole Location Map Showing Gradient IP AnomalyFigure 4: Richards Breccia: Section along R2301Figure 4: Richards Breccia: Section along R2301Figure 5: Richards Breccia: Section along R2304Figure 5: Richards Breccia: Section along R2304Figure 6: Alkalic Porphyry Deposit Clusters ComparisonFigure 6: Alkalic Porphyry Deposit Clusters ComparisonHighlights 2023 JR Zone Drill Program Richards BrecciaR23-01: 38.63 m @ 1.17% Cu Eq (76.37 to 115 m) R23-04: 50.17 m @ 1.00% Cu Eq (79...

Preliminary unaudited data, consolidated sales revenue of “Vilvi Group“ for nine months of 2023 amounted to 153.87 million EUR – 12.4% decreased comparing to the same period last year (sales revenue for the first nine months of 2022 amounted to 175.67 million EUR). During three quarters of 2023 the Group earned 10.56 million EUR net profit or 14.4 percent less than the same period last year (net profit for the three quarters of 2022 was EUR 12.33 million).    Vilija Milaseviciute    Economics and finance director    Phone: +370 441 55 102AttachmentThe results of nine months 2023

TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced the pricing of its previously announced underwritten public offering in the United States (the “Offering”). The Offering consists of 1,600,000 common shares of the Company and warrants to purchase 1,600,000 common shares of the Company at a public offering price of US$0.90 (CAD$1.22) per common share and accompanying warrant. Each warrant is exercisable at an exercise price of US$1.12 (CAD$1.52) per common share for a period of five years from issuance. Gross proceeds from the Offering are expected...

LUXEMBOURG, Nov. 30, 2023 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that Hubzu, Altisource’s industry leading online auction marketplace, has expanded its collaboration with NCST (National Community Stabilization Trust), a national nonprofit housing organization, to bolster the supply of affordable, single-family homes. This strategic collaboration will offer Hubzu homes that are available for sale under the Federal Housing Administration (FHA) Claims Without Conveyance of Title (CWCOT) second chance program to NCST and their dedicated community of buyers, fortifying neighborhood stability, fostering community wealth, and promoting racial equity. For years, Hubzu has worked...

FORT WORTH, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that the Journal of Surgery has published a retrospective study on CellerateRX® Surgical Powder (“CellerateRX”) titled “Activated Collagen Powder Significantly Reduces Surgical Site Infections in Patients Undergoing Elective Surgery”. Zach Fleming, Sanara’s CEO stated, “This study demonstrates that the use of CellerateRX can have a significant impact on surgical patients’ outcomes by promoting wound healing and helping to prevent...

BERKELEY HEIGHTS, N.J., Nov. 30, 2023 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), by filing its quarterly report on Form 10-Q for the period ended September 30, 2023, on November 29, 2023 with the Securities and Exchange Commission. Nasdaq Listing Qualifications Department staff has determined that the Company complies with the Rule and advised that the matter is now closed. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company...

Matterport’s Property Marketing Solution will become an integral part of Vacasa’s home onboarding and guest experience for the tens of thousands of properties Vacasa manages SUNNYVALE, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading digital twin platform to access, understand and utilize properties, and Vacasa, Inc. (Nasdaq: VCSA), North America’s leading vacation rental management platform, today announced a new multi-year partnership to leverage Matterport’s Digital Twin Platform and Capture Services. Vacasa will expand its use of Matterport’s Digital Twin Platform as an integral part of its home onboarding and guest service experiences for the tens of thousands of properties Vacasa manages. Matterport’s full-stack digital twin solutions will enable Vacasa to more efficiently and effectively...

Full Truck Alliance (FTA)Dr. Chen Zhaohui presented FTA’s methods for reducing trucking emissions at COP28Dubai, Nov. 30, 2023 (GLOBE NEWSWIRE) — As COP 28 seeks to get commitments from countries and industries to drastically reduce emissions across all sectors, Full Truck Alliance (FTA) showcased its strategy for a greener, technology-driven trucking sector with lower emissions. Dr. Chen Zhaohui, FTA’s Principal Scientist, spoke during a panel on Nov. 30 about international private sector collaboration to meet emission reduction targets, explaining FTA’s pledge to lead in reducing trucking emissions in China. The strategy includes novel ways of reducing diesel consumption from trucking by billions of liters each year. The transportation sector accounts for about a quarter of global greenhouse gas emissions. In the...

Enhanced 250kg manufacturing facility assures increased capacity to meet rapidly growing ZTlido® demand. Two new patents previously announced covering ZTlido® in the U.S. ensures proprietary protection through January 2031PALO ALTO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced the successful completion of a Good Manufacturing Practices (GMP) inspection by the U.S. Food and Drug Administration (FDA) of the enhanced manufacturing facility of Oishi Koseido Co., Ltd. (Oishi) for ZTlido® located in Tosu, Saga, Japan. This successful audit allows Scilex to continue commercializing ZTlido®...